1. Home
  2. WVE vs CRVL Comparison

WVE vs CRVL Comparison

Compare WVE & CRVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

N/A

Current Price

$13.35

Market Cap

2.4B

Sector

Health Care

ML Signal

N/A

Logo CorVel Corp.

CRVL

CorVel Corp.

N/A

Current Price

$51.87

Market Cap

2.8B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
WVE
CRVL
Founded
2012
1987
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Specialty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.8B
IPO Year
2015
1995

Fundamental Metrics

Financial Performance
Metric
WVE
CRVL
Price
$13.35
$51.87
Analyst Decision
Strong Buy
Analyst Count
15
0
Target Price
$31.47
N/A
AVG Volume (30 Days)
2.2M
216.9K
Earning Date
01-01-0001
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.53
Revenue
$3,704,000.00
$895,589,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$119.93
N/A
P/E Ratio
N/A
$33.86
Revenue Growth
149.43
12.61
52 Week Low
$5.28
$44.83
52 Week High
$21.73
$117.70

Technical Indicators

Market Signals
Indicator
WVE
CRVL
Relative Strength Index (RSI) 47.54 41.50
Support Level $12.53 $47.00
Resistance Level $14.56 $55.33
Average True Range (ATR) 0.79 1.92
MACD 0.01 0.70
Stochastic Oscillator 23.84 54.32

Price Performance

Historical Comparison
WVE
CRVL

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About CRVL CorVel Corp.

CorVel Corp applies technology including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. It partners with employers, third-party administrators, insurance companies, and government agencies in managing worker's compensation and health, auto, and liability services. The company's solutions combine integrated technologies with a human touch providing services that include claims management, bill review, preferred provider networks, utilization management, case management, pharmacy services, directed care, and medicare services.

Share on Social Networks: